LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $286,384 | -2.7% | 3,949 | -1.1% | 0.00% | – |
| Q1 2023 | $294,435 | +30.3% | 3,993 | +57.7% | 0.00% | – |
| Q3 2022 | $226,000 | -30.2% | 2,532 | -30.3% | 0.00% | – |
| Q2 2022 | $324,000 | -29.7% | 3,632 | -10.0% | 0.00% | -100.0% |
| Q1 2022 | $461,000 | +124.9% | 4,034 | +207.0% | 0.00% | – |
| Q4 2021 | $205,000 | -57.1% | 1,314 | -73.4% | 0.00% | -100.0% |
| Q3 2020 | $478,000 | -60.1% | 4,934 | -53.9% | 0.00% | -50.0% |
| Q2 2020 | $1,198,000 | +140.6% | 10,714 | +54.7% | 0.00% | +100.0% |
| Q1 2020 | $498,000 | +142.9% | 6,926 | +256.6% | 0.00% | – |
| Q4 2019 | $205,000 | -71.2% | 1,942 | -72.9% | 0.00% | -100.0% |
| Q3 2019 | $712,000 | -94.0% | 7,157 | -93.1% | 0.00% | -95.5% |
| Q2 2019 | $11,870,000 | -38.1% | 103,992 | -31.8% | 0.02% | -37.1% |
| Q1 2019 | $19,179,000 | +243.1% | 152,564 | +270.4% | 0.04% | +250.0% |
| Q4 2018 | $5,590,000 | +102.1% | 41,194 | +308.3% | 0.01% | +150.0% |
| Q3 2018 | $2,766,000 | +59.4% | 10,090 | +20.5% | 0.00% | +33.3% |
| Q2 2018 | $1,735,000 | -46.1% | 8,376 | -57.0% | 0.00% | -40.0% |
| Q1 2018 | $3,217,000 | -31.7% | 19,477 | -43.4% | 0.01% | -28.6% |
| Q4 2017 | $4,711,000 | +1.6% | 34,406 | +1.1% | 0.01% | 0.0% |
| Q3 2017 | $4,635,000 | -11.9% | 34,048 | -21.4% | 0.01% | -30.0% |
| Q2 2017 | $5,262,000 | +6.7% | 43,344 | -7.0% | 0.01% | 0.0% |
| Q1 2017 | $4,932,000 | +3.4% | 46,595 | -0.7% | 0.01% | -9.1% |
| Q4 2016 | $4,768,000 | +28.7% | 46,929 | +29.3% | 0.01% | +22.2% |
| Q3 2016 | $3,704,000 | +14.5% | 36,294 | +33.9% | 0.01% | 0.0% |
| Q2 2016 | $3,234,000 | +13.9% | 27,114 | +2.3% | 0.01% | +12.5% |
| Q1 2016 | $2,839,000 | +10.3% | 26,514 | +11.6% | 0.01% | +33.3% |
| Q4 2015 | $2,575,000 | +6.4% | 23,753 | -15.9% | 0.01% | 0.0% |
| Q3 2015 | $2,419,000 | -14.1% | 28,238 | +1.2% | 0.01% | 0.0% |
| Q2 2015 | $2,815,000 | +24.1% | 27,901 | -5.2% | 0.01% | +50.0% |
| Q1 2015 | $2,269,000 | +44.1% | 29,426 | -0.6% | 0.00% | +33.3% |
| Q4 2014 | $1,575,000 | +26.7% | 29,598 | +11.8% | 0.00% | 0.0% |
| Q3 2014 | $1,243,000 | – | 26,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |